Article & News

Modern drug research rarely stays within a single experimental system. A candidate may move from antigen or target validation to cellular assays, animal studies, immune

The rise of therapeutic cancer vaccines has made preclinical assessment more sophisticated than measuring tumor size alone. Oncology vaccine evaluation may need to address antigen-specific immune

Drug development rarely depends on one experimental method. Drug efficacy evaluation connects a candidate treatment with measurable biological outcomes, but the appropriate testing strategy depends on